Trajkova S, Stavridis IP, Stojanovic A, Petrusevska G, Dukovski D, Ivanovski M, Veljanovska AP, Simjanovska MP, Cadievski L, Cevreska L. Immunoblastic morphology as a possible prognostic indicator for the outcome of the patients with diffuse large B cell lymphoma in era of the rituximab based treatment: single centre experience. Int J Res Med Sci [Internet]. 2017 Jan. 26 [cited 2026 Apr. 16];1(2):47-52. Available from: https://www.msjonline.org/index.php/ijrms/article/view/2556